Is MRI the 'mammography' of prostate cancer screening?

March 27, 2017 by Steven Reinberg, Healthday Reporter

(HealthDay)—MRI screening might greatly reduce overdiagnosis and overtreatment of prostate cancer in older men, a preliminary study suggests.

Compared to the current screening method, MRI can reduce overdiagnosis of by 50 percent, and unnecessary biopsies by 70 percent in men over 70, Dutch researchers reported Saturday at a conference in England.

Prostate is common in aging men, but it's often slow-growing and non-threatening.

Screening sometimes begins with a blood test to measure the level of PSA (). If elevated, it might indicate cancer. So, the next step is a needle biopsy, where a doctor takes multiple samples from the and has them tested for cancer.

Because PSA testing is an inexact science, "the benefit of early prostate cancer detection with random biopsy generally does not outweigh the harm induced by screening," particularly in men 70 and older, said lead researcher Dr. Arnout Alberts.

These harms can include unnecessary radiation and surgery, explained Alberts, who is in the urology department at Erasmus University Medical Center in Rotterdam, the Netherlands.

However, some elderly men may benefit from early detection, "and the use of MRI scans significantly reduces the harms and drawbacks of screening," he said.

For the study, Alberts and colleagues focused on 335 men, aged 71 and older, who had elevated blood PSA levels.

To determine who did and did not have prostate cancer, the investigators took six biopsy samples from the prostates of 177 men. Another 158 men had 12 samples taken, plus an MRI scan of their prostate before the biopsy.

If the MRI revealed a potentially cancerous area, then further MRI-targeted samples were taken, Alberts explained.

The research team found that biopsies using either six or 12 samples were, in most cases, able to detect serious cancers.

However, Alberts' team found that 70 percent of the men in the study would not have needed biopsies at all if MRI had been used beforehand, because no suspicious areas showed up on their scans.

Although MRI is more expensive than PSA testing, it could save money in the long run, in much the same way that mammography has paid off for women, the researchers suggested.

One specialist, however, doesn't think MRI is the answer to the controversy.

"There is not enough data to say MRI is a home run, and there is not enough data to say it is cost-effective," said Dr. Anthony D'Amico, a professor of radiation oncology at Harvard Medical School in Boston.

Data from other institutions shows that MRI finds only 80 percent of severe cancers and misses 50 percent of the other high-grade cancers, D'Amico said.

"So having a negative MRI doesn't mean that you don't have aggressive prostate cancer," he added.

Alberts countered that a larger trial has started, with 40,000 men randomly selected for MRI screening at various PSA levels or for no screening.

"This trial will hopefully further elucidate the role of MRI in prostate cancer screening," he said.

D'Amico believes the only way to know for sure if MRI effectively screens for prostate cancer is to scan thousands of patients and remove their prostate to analyze the type of cancer.

"This would need to be done before we could justify the cost of MRI, which could be several thousand dollars, as opposed to a PSA, which is in the $50 to $70 range," D'Amico said.

D'Amico said MRI might be of value in certain cases, however.

"If you have a high PSA and you have biopsies and they are all negative, consider MRI, not for , but because you probably have a cancer that has gone undetected," he said. "But if you don't have a high PSA, we shouldn't be using MRI as a substitute for PSA."

The study results were scheduled for presentation Saturday at a European Association of Urology conference in London. Findings presented at meetings are usually considered preliminary until published in a peer-reviewed medical journal.

Explore further: MRI scans for suspected prostate cancer could improve diagnosis

More information: Arnout Alberts, M.D., department of urology, Erasmus University Medical Center, Rotterdam, the Netherlands; Anthony D'Amico, M.D., Ph.D., professor, radiation oncology, Harvard Medical School, Boston; March 25, 2017, presentation, European Association of Urology Conference, London, U.K.

For more about prostate cancer, visit the American Cancer Society.

Related Stories

MRI scans for suspected prostate cancer could improve diagnosis

January 31, 2017
A researcher from Hull York Medical School (HYMS) has helped design and set up a study which has been hailed as the biggest leap in diagnosing prostate cancer in decades.

One in four men with suspected prostate cancer could avoid unnecessary biopsy if given an MRI scan first

January 20, 2017
Giving men with suspected prostate cancer an MRI scan could improve diagnosis and save those who do not have aggressive cancers from having an unnecessary biopsy, according to a study published in The Lancet.

MRI feasible for predicting prostate CA in unselected sample

July 18, 2016
(HealthDay)—Prostate multiparametric magnetic resonance imaging (MRI) is feasible for predicting prostate cancer in an unselected sample of the general population, according to a study published in the August issue of The ...

Alternative PSA screening strategies could reduce harm

February 5, 2013
(HealthDay)—Compared with standard screening, alternative prostate-specific antigen (PSA) screening strategies could maintain good prostate cancer detection rates while reducing overdiagnoses and unnecessary biopsies, according ...

Impact of 2012 USPSTF guideline against PSA screening explored

December 29, 2015
(HealthDay)—Patients undergoing prostate needle biopsies after the 2012 U.S. Preventive Services Task Force (USPSTF) recommendation against prostate-specific antigen-based screening for prostate cancer for men of any age ...

Expert panel suggests PSA test may benefit some men

July 16, 2012
(HealthDay) -- Men with a life expectancy of more than 10 years should talk with their doctor about getting a prostate-specific antigen (PSA) test for prostate cancer, an expert panel recommends.

Recommended for you

Two ways cancer resists treatment are actually connected, with one activating the other

December 18, 2018
Drugs that target BRAF and MEK in cancer have shown promise in treating a subset of melanoma that carries a mutation in the BRAF gene, but drug resistance usually emerges, reversing the benefit of these drugs and limiting ...

HPV discovery raises hope for new cervical cancer treatments

December 18, 2018
Researchers at the University of Virginia School of Medicine have made a discovery about human papillomavirus (HPV) that could lead to new treatments for cervical cancer and other cancers caused by the virus.

Vaccine, checkpoint drugs combination shows promise for pancreatic cancers

December 18, 2018
Researchers at the Johns Hopkins Kimmel Cancer Center discovered a combination of a cancer vaccine with two checkpoint drugs reduced pancreatic cancer tumors in mice, demonstrating a possible pathway for treatment of people ...

Researchers identify ways breast cancer avoids immune system detection

December 18, 2018
Recent breakthroughs in immunotherapy are making a huge difference in treating some forms of cancer, especially metastatic cancer. But breast cancer has proven a tricky foe for this new therapy, and an interdisciplinary team ...

Metal chemotherapy drugs boost the impact of immunotherapy in cancer

December 18, 2018
Due to their powerful tumour-killing effect, metal-based chemotherapies are frequently used in cancer treatment. However, it was hitherto assumed that they damaged the immune system, because of their cytotoxic (cell-damaging) ...

10-year follow-up after negative colonoscopies linked to lower colorectal cancer risk

December 17, 2018
Ten years after a negative colonoscopy, Kaiser Permanente members had 46 percent lower risk of being diagnosed with and were 88 percent less likely to die from colorectal cancer compared with those who did not undergo colorectal ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.